Theralase Technologies Inc. (TLTFF)
USD 0.19
(4.11%)
USD 0.19
(4.11%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 386.88 Thousand CAD | -18.31% |
| 2022 | 473.62 Thousand CAD | 1225.78% |
| 2021 | 35.72 Thousand CAD | -61.31% |
| 2020 | 92.34 Thousand CAD | -36.15% |
| 2019 | 144.62 Thousand CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | -100.0% |
| 2013 | 778.00 CAD | -45.78% |
| 2012 | 1435.00 CAD | -75.1% |
| 2011 | 5764.00 CAD | -84.47% |
| 2010 | 37.12 Thousand CAD | -31.99% |
| 2009 | 54.58 Thousand CAD | 123.96% |
| 2008 | 24.37 Thousand CAD | 0.0% |
| 2007 | - CAD | -100.0% |
| 2006 | 70 Thousand CAD | 133.33% |
| 2005 | 30 Thousand CAD | -61.65% |
| 2004 | 78.23 Thousand CAD | -37.41% |
| 2003 | 125 Thousand CAD | 0.0% |
| 2002 | - CAD | 0.0% |
| 2001 | - CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 341.18 Thousand CAD | -6.33% |
| 2024 Q1 | 364.23 Thousand CAD | -5.85% |
| 2023 Q4 | 386.88 Thousand CAD | -5.44% |
| 2023 FY | 386.88 Thousand CAD | -18.31% |
| 2023 Q2 | 431 Thousand CAD | -4.75% |
| 2023 Q3 | 409.13 Thousand CAD | -5.07% |
| 2023 Q1 | 452.5 Thousand CAD | -4.46% |
| 2022 FY | 473.62 Thousand CAD | 1225.78% |
| 2022 Q4 | 473.62 Thousand CAD | -2.84% |
| 2022 Q3 | 487.45 Thousand CAD | -1.39% |
| 2022 Q1 | 20.85 Thousand CAD | -41.64% |
| 2022 Q2 | 494.32 Thousand CAD | 2270.86% |
| 2021 Q4 | 35.72 Thousand CAD | -28.98% |
| 2021 FY | 35.72 Thousand CAD | -61.31% |
| 2021 Q1 | 78.6 Thousand CAD | -14.87% |
| 2021 Q2 | 64.59 Thousand CAD | -17.82% |
| 2021 Q3 | 50.3 Thousand CAD | -22.13% |
| 2020 Q1 | 131.94 Thousand CAD | -8.77% |
| 2020 Q2 | 119 Thousand CAD | -9.81% |
| 2020 FY | 92.34 Thousand CAD | -36.15% |
| 2020 Q4 | 92.34 Thousand CAD | -12.72% |
| 2020 Q3 | 105.8 Thousand CAD | -11.09% |
| 2019 Q2 | 168.67 Thousand CAD | 0.0% |
| 2019 Q3 | 157.05 Thousand CAD | -6.89% |
| 2019 Q1 | - CAD | 0.0% |
| 2019 Q4 | 144.62 Thousand CAD | -7.92% |
| 2019 FY | 144.62 Thousand CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2014 FY | - CAD | -100.0% |
| 2014 Q4 | - CAD | -100.0% |
| 2014 Q3 | 336.00 CAD | -24.83% |
| 2014 Q2 | 447.00 CAD | -24.11% |
| 2014 Q1 | 589.00 CAD | -24.29% |
| 2013 FY | 778.00 CAD | -45.78% |
| 2013 Q4 | 778.00 CAD | -18.7% |
| 2013 Q2 | 1126.00 CAD | -12.37% |
| 2013 Q1 | 1285.00 CAD | -10.45% |
| 2013 Q3 | 957.00 CAD | -15.01% |
| 2012 Q2 | 1709.00 CAD | -53.79% |
| 2012 Q1 | 3698.00 CAD | -35.84% |
| 2012 FY | 1435.00 CAD | -75.1% |
| 2012 Q3 | 1576.00 CAD | -7.78% |
| 2012 Q4 | 1435.00 CAD | -8.95% |
| 2011 FY | 5764.00 CAD | -84.47% |
| 2011 Q1 | 11.7 Thousand CAD | -68.48% |
| 2011 Q2 | 9765.00 CAD | -16.55% |
| 2011 Q4 | 5764.00 CAD | -25.97% |
| 2011 Q3 | 7786.00 CAD | -20.27% |
| 2010 Q2 | 46.97 Thousand CAD | -6.72% |
| 2010 FY | 37.12 Thousand CAD | -31.99% |
| 2010 Q4 | 37.12 Thousand CAD | -13.05% |
| 2010 Q1 | 50.36 Thousand CAD | -7.73% |
| 2010 Q3 | 42.69 Thousand CAD | -9.12% |
| 2009 FY | 54.58 Thousand CAD | 123.96% |
| 2009 Q1 | 108.07 Thousand CAD | 343.45% |
| 2009 Q2 | 130.27 Thousand CAD | 20.54% |
| 2009 Q3 | 104.11 Thousand CAD | -20.08% |
| 2009 Q4 | 54.58 Thousand CAD | -47.58% |
| 2008 Q1 | - CAD | 0.0% |
| 2008 FY | 24.37 Thousand CAD | 0.0% |
| 2008 Q4 | 24.37 Thousand CAD | -32.3% |
| 2008 Q3 | 36 Thousand CAD | -44.62% |
| 2008 Q2 | 65 Thousand CAD | 0.0% |
| 2007 Q1 | 80.1 Thousand CAD | 14.43% |
| 2007 Q2 | 95 Thousand CAD | 18.6% |
| 2007 Q4 | - CAD | 0.0% |
| 2007 Q3 | - CAD | -100.0% |
| 2007 FY | - CAD | -100.0% |
| 2006 Q4 | 70 Thousand CAD | 180.0% |
| 2006 Q1 | 105 Thousand CAD | 250.0% |
| 2006 Q2 | 45 Thousand CAD | -57.14% |
| 2006 FY | 70 Thousand CAD | 133.33% |
| 2006 Q3 | 25 Thousand CAD | -44.44% |
| 2005 FY | 30 Thousand CAD | -61.65% |
| 2005 Q1 | 79.78 Thousand CAD | 1.97% |
| 2005 Q2 | 2092.00 CAD | -97.38% |
| 2005 Q3 | - CAD | -100.0% |
| 2005 Q4 | 30 Thousand CAD | 0.0% |
| 2004 Q4 | 78.23 Thousand CAD | -21.76% |
| 2004 Q3 | 100 Thousand CAD | -4.76% |
| 2004 Q1 | 105 Thousand CAD | -16.0% |
| 2004 FY | 78.23 Thousand CAD | -37.41% |
| 2004 Q2 | 105 Thousand CAD | 0.0% |
| 2003 Q3 | - CAD | 0.0% |
| 2003 Q4 | 125 Thousand CAD | 0.0% |
| 2003 Q2 | - CAD | 0.0% |
| 2003 Q1 | - CAD | 0.0% |
| 2003 FY | 125 Thousand CAD | 0.0% |
| 2002 Q4 | - CAD | 0.0% |
| 2002 FY | - CAD | 0.0% |
| 2002 Q1 | - CAD | 0.0% |
| 2002 Q2 | - CAD | 0.0% |
| 2002 Q3 | - CAD | 0.0% |
| 2001 FY | - CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | 60 Thousand USD | -544.8% |
| Össur hf. | 467.73 Million USD | 99.917% |
| QHSLab, Inc. | 1.78 Million USD | 78.284% |
| Wellstar International, Inc. | 51.36 Million USD | 99.247% |
| Össur hf. | 467.73 Million USD | 99.917% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 524.71 Thousand USD | 26.269% |
| Aurora Spine Corporation | 2.67 Million USD | 85.513% |
| BrainsWay Ltd. | 471 Thousand USD | 17.86% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | 13.928% |
| CVR Medical Corp. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 27.81 Million USD | 98.609% |
| BioElectronics Corporation | 14.83 Million USD | 97.391% |
| Vivos Inc. | - USD | -Infinity% |
| Kelyniam Global, Inc. | 496.39 Thousand USD | 22.063% |
| Zecotek Photonics Inc. | 3.22 Million USD | 87.992% |
| REMSleep Holdings, Inc. | 178.11 Thousand USD | -117.209% |
| EKF Diagnostics Holdings plc | 5.21 Million USD | 92.586% |
| Avitar, Inc. | 5.26 Million USD | 92.652% |
| Nanomix Corporation | 11.4 Million USD | 96.608% |
| Theraclion SA | 1.95 Million EUR | 80.167% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 4.04 Million USD | 90.428% |
| NewCardio, Inc. | 3 Million USD | 87.104% |
| Positron Corporation | 1.78 Million USD | 78.357% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.69 Million USD | 77.223% |
| Lombard Medical, Inc. | 32.29 Million USD | 98.802% |
| ALR Technologies Inc. | 19.26 Million USD | 97.992% |
| Stratec SE | 156.16 Million USD | 99.752% |
| Vycor Medical, Inc. | 1.11 Million USD | 65.154% |
| Heart Tronics, Inc. | 209.28 Thousand USD | -84.858% |
| Nu-Med Plus, Inc. | 100 Thousand USD | -286.88% |
| MicroPort Scientific Corporation | 1.69 Billion USD | 99.977% |
| VMS Rehab Systems, Inc. | 133.52 USD | -289654.344% |
| Guided Therapeutics, Inc. | 2.05 Million USD | 81.201% |
| Ingen Technologies, Inc. | 631.15 Thousand USD | 38.703% |
| CYduct Diagnostics, Inc. | 670 Thousand USD | 42.257% |
| Odyssey Group International, Inc. | 2.14 Million USD | 81.961% |
| SANUWAVE Health, Inc. | 31.94 Million USD | 98.789% |
| IR-Med Inc. | 161 Thousand USD | -140.298% |
| Perimeter Medical Imaging AI, Inc. | 192.89 Thousand USD | -100.566% |
| United American Healthcare Corporation | - USD | -Infinity% |
| Polarean Imaging plc | 216.38 Thousand USD | -78.792% |
| ECGI Holdings, Inc. | 3.17 Million USD | 87.8% |
| Capital Group Holdings, Inc. | 4944.00 USD | -7725.243% |
| ADM Tronics Unlimited, Inc. | 799.65 Thousand USD | 51.619% |
| Medical Supply International USA, Inc. | 227 Thousand USD | -70.43% |
| Rapid Therapeutic Science Laboratories, Inc. | 3.83 Million USD | 89.9% |
| Nexeon MedSystems Inc. | 4.21 Million USD | 90.822% |
| SS Innovations International, Inc. | 8.21 Million USD | 95.292% |
| Urologix, Inc. | 5.33 Million USD | 92.746% |
| Qualis Innovations, Inc. | 9102.00 USD | -4150.494% |
| Smith & Nephew plc | 3.07 Billion USD | 99.987% |
| NIOX Group Plc | 1.4 Million USD | 72.372% |
| Fuse Medical, Inc. | 1.99 Million USD | 80.595% |
| Broncus Holding Corporation | 2.35 Million USD | 83.568% |
| Brain Scientific Inc. | 2.86 Million USD | 86.489% |
| Pressure BioSciences, Inc. | 22.75 Million USD | 98.3% |
| Health Logic Interactive Inc. | 40.44 Thousand USD | -856.629% |